C12Y 403/01024
Phenylalanine ammonia-lyase
Official title: Phenylalanine ammonia-lyase (4.3.1.24)
C12Y403/01024 (Phenylalanine ammonia-lyase) appears on 64 US grants and 134 published applications in this corpus.
Search patents in C12Y- Granted patents
- 64
- Published applications
- 134
- Assignees
- 52
- Inventors
- 239
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 1 | 2 |
| 2014 | 0 | 1 |
| 2015 | 1 | 7 |
| 2016 | 0 | 6 |
| 2017 | 2 | 7 |
| 2018 | 5 | 16 |
| 2019 | 14 | 15 |
| 2020 | 10 | 15 |
| 2021 | 9 | 6 |
| 2022 | 5 | 11 |
| 2023 | 3 | 12 |
| 2024 | 7 | 14 |
| 2025 | 2 | 13 |
| 2026 | 5 | 5 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method for the biosynthesis of diosmin and/or hesperidin in a microorganism29 Sep 2026US 12,747,464 B2Les Laboratoires Servier
- Recombinant host cells with improved production of tetraketide derivatives22 Sep 2026US 12,742,189 B2Iptector Assets Aps
- Method for producing chain unsaturated carboxylic acid compound using phenylalanine ammonia layse15 Sep 2026US 12,735,693 B2Riken
- Enumeration of genetically engineered microorganisms by live cell counting techniques1 Sep 2026US 12,721,882 B2Synlogic Operating Company, Inc.
- Applying optogenetic amplifier circuits for multi-phase light controlled microbial fermentations20 Jan 2026US 12,529,038 B2The Trustees of Princeton University
- Tropane Alkaloid (TA) Producing Non-Plant Host Cells, and Methods of Making and Using the Same17 Sep 2026US 2026/0275357 A1The Board of Trustees of the Leland Stanford Junior University
- Recombinant host cells with improved production of tetraketide derivatives27 Aug 2026US 2026/0250728 A1Iptector Assets Aps
- Applying optogenetic amplifier circuits for multi-phase light controlled microbial fermentations16 Jul 2026US 2026/0201345 A1The Trustees of Princeton University
- Recombinant bacteria expressing phenylalanine ammonia lyase, phenylalanine transporter and l-amino acid deaminase for reducing hyperphenylalaninemia21 May 2026US 2026/0137729 A1Synlogic Operating Company, Inc.
- Pal variant, pharmaceutical composition containing pal variant, and method for preparing pal variant29 Jan 2026US 2026/0027219 A1Zektar Biopharmaceuticals (Zhejiang) Co., Ltd.
Most cited
By later US patents
- Synthetic membrane-receiver complexes35US 9,644,180 B2Rubius Therapeutics, Inc. · 2017
- Bacteria engineered to treat a disease or disorder23US 9,889,164 B2Synlogic, Inc. · 2018
- Synthetic membrane-receiver complexes18US 10,329,531 B2Rubius Therapeutics, Inc. · 2019
- Engineered phenylalanine ammonia lyase polypeptides18US 9,611,468 B2Codexis, Inc. · 2017
- Synthetic membrane-receiver complexes15US 10,253,296 B2Rubius Therapeutics, Inc. · 2019